GB9106648D0
(en)
*
|
1991-03-28 |
1991-05-15 |
Rhone Poulenc Rorer Ltd |
New inhaler
|
US6029661A
(en)
*
|
1991-08-26 |
2000-02-29 |
3M Innovative Properties Company |
Powder dispenser
|
AU683036B2
(en)
*
|
1992-12-18 |
1997-10-30 |
Merck Sharp & Dohme Corp. |
Inhaler for powdered medications
|
AU6643794A
(en)
*
|
1993-05-24 |
1994-12-20 |
Franco Del Bon |
Inhaler
|
DE4319514C2
(de)
*
|
1993-06-14 |
2003-06-18 |
Sofotec Gmbh & Co Kg |
Pulverinhalator
|
DE4340768A1
(de)
*
|
1993-11-30 |
1995-06-01 |
Bayer Ag |
Vorrichtung zum Inhalieren
|
FI95441C
(fi)
*
|
1994-05-31 |
1996-02-12 |
Leiras Oy |
Inhalointilaitteen lääkeainekammio
|
WO1996008303A1
(fr)
*
|
1994-09-14 |
1996-03-21 |
Nippondenso Co., Ltd. |
Filtre desodorisant
|
AU730625B2
(en)
*
|
1994-09-16 |
2001-03-08 |
Laboratoire Glaxo Wellcome S.A. |
Inhalation device
|
NZ293269A
(en)
*
|
1994-09-16 |
1998-07-28 |
Glaxo Wellcome Lab |
Inhaled medicament dispenser comprises movable metering recess which communicates with reservoir and outlet
|
US5901703A
(en)
*
|
1995-02-06 |
1999-05-11 |
Unisia Jecs Corporation |
Medicine administering device for nasal cavities
|
US5714007A
(en)
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
DE19545226C1
(de)
|
1995-12-05 |
1997-06-19 |
Boehringer Ingelheim Int |
Sperrspannwerk für einen federbetätigten Abtrieb
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5871010A
(en)
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
EP1350532B1
(en)
*
|
1997-01-30 |
2008-04-09 |
Hitachi, Ltd. |
Capsule type powder Inhaler
|
US5881720A
(en)
*
|
1997-04-29 |
1999-03-16 |
The Procter & Gamble Company |
Method of delivering halotherapy
|
TW533865U
(en)
*
|
1997-06-10 |
2003-05-21 |
Glaxo Group Ltd |
Dispenser for dispensing medicament and actuation indicating device
|
JP4423457B2
(ja)
|
1998-01-16 |
2010-03-03 |
トルーデル メディカル インターナショナル |
ディスペンサおよび投与装置用表示装置
|
US6142339A
(en)
|
1998-01-16 |
2000-11-07 |
1263152 Ontario Inc. |
Aerosol dispensing device
|
US6082358A
(en)
|
1998-05-05 |
2000-07-04 |
1263152 Ontario Inc. |
Indicating device for aerosol container
|
US6336453B1
(en)
|
1999-04-30 |
2002-01-08 |
Trudell Medical International |
Indicating device for aerosol container
|
US6729330B2
(en)
|
1998-05-05 |
2004-05-04 |
Trudell Medical International |
Indicating device for aerosol container
|
US6149774A
(en)
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
DE19846382C1
(de)
*
|
1998-10-08 |
2000-07-06 |
Pari Gmbh |
Zählwerk und seine Verwendung in Inhalatoren, Verneblern oder ähnlichen Dosieraerosolvorrichtungen
|
AU3929500A
(en)
*
|
1999-03-31 |
2000-10-16 |
Shofner Engineering Associates, Inc. |
Controlled deliveries and depositions of pharmaceutical and other aerosolized masses
|
US6854460B1
(en)
|
1999-03-31 |
2005-02-15 |
Shofner Engineering Associates, Inc. |
Controlled deliveries and depositions of pharmaceutical and other aerosolized masses
|
FI990915A0
(fi)
*
|
1999-04-23 |
1999-04-23 |
Orion Yhtymae Oyj |
Jauheinhalaattori
|
US6923979B2
(en)
*
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
ATE294608T1
(de)
|
1999-06-05 |
2005-05-15 |
Innovata Biomed Ltd |
Verabreichungsystem für medikamente
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
KR100701904B1
(ko)
|
1999-08-21 |
2007-04-02 |
알타나 파마 아게 |
Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
ATE392885T1
(de)
|
2000-02-28 |
2008-05-15 |
Pharmakodex Ltd |
Verabreichungssystemen für oral anzuwendende arzneimittel
|
FI20000810A0
(fi)
|
2000-04-06 |
2000-04-06 |
Orion Yhtymae Oyj |
Jauheinhalaattori
|
GB2364919A
(en)
*
|
2000-07-21 |
2002-02-13 |
Cambridge Consultants |
Inhalers
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
EP1238680B1
(en)
*
|
2001-03-05 |
2003-12-10 |
Ivo Pera |
Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract
|
ITMI20010428A1
(it)
*
|
2001-03-02 |
2002-09-02 |
Chemo Breath S A |
Composizioni ad uso inalatorio a base di formoterolo
|
US6745760B2
(en)
|
2001-05-15 |
2004-06-08 |
Trudell Medical International |
Medicament applicator
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
US7767872B2
(en)
*
|
2001-09-06 |
2010-08-03 |
Mpg Biotechnologies, Llc |
Thimerosal removal device
|
US8440791B2
(en)
*
|
2001-09-06 |
2013-05-14 |
Mgp Biotechnologies, Llc |
Thimerosal removal device
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
TWI347845B
(en)
|
2002-03-06 |
2011-09-01 |
Nycomed Gmbh |
Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
|
AU2003209475A1
(en)
*
|
2002-03-07 |
2003-09-16 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
US7004164B2
(en)
|
2002-03-21 |
2006-02-28 |
Trudell Medical International |
Indicating device for aerosol container
|
US7396341B2
(en)
*
|
2002-08-28 |
2008-07-08 |
Boehringer Ingelheim International Gmbh |
Blocking device for a locking stressing mechanism having a spring-actuated output drive device
|
AU2002368278A1
(en)
|
2002-09-16 |
2004-05-04 |
Alfred Von Schuckmann |
Inhaler for powdery, in particular, medical substances
|
EP1905474A3
(de)
*
|
2002-09-16 |
2008-04-16 |
von Schuckmann, Alfred |
Inhalator für pulverförmige, insbesondere medizinische Substanzen
|
EP1452198A4
(en)
*
|
2002-10-11 |
2006-11-02 |
Otsuka Pharma Co Ltd |
INHALATION DEVICE FOR POWDER
|
US7051731B1
(en)
|
2002-11-15 |
2006-05-30 |
Rogerson L Keith |
Oxygen delivery system
|
WO2004052374A1
(en)
|
2002-12-12 |
2004-06-24 |
Altana Pharma Ag |
Combination medicament
|
US20040206350A1
(en)
*
|
2002-12-19 |
2004-10-21 |
Nektar Therapeutics |
Aerosolization apparatus with non-circular aerosolization chamber
|
DE10300984A1
(de)
*
|
2003-01-14 |
2004-07-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Kapsel zur Aufnahme eines inhalativ applizierbaren Wirkstoffs
|
MY143936A
(en)
|
2003-03-27 |
2011-07-29 |
Nycomed Gmbh |
Process for preparing crystalline ciclesonide with defined particle size
|
US8869794B1
(en)
*
|
2003-04-09 |
2014-10-28 |
Novartis Pharma Ag |
Aerosolization apparatus with capsule puncturing member
|
DK1610850T3
(da)
|
2003-04-09 |
2012-06-25 |
Novartis Ag |
Aerosolapparat med luftindløbsskærm
|
US20060293293A1
(en)
*
|
2003-05-22 |
2006-12-28 |
Altana Pharma Ag |
Salmeterol and ciclesonide combination
|
GB0312148D0
(en)
*
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
GB0315889D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
WO2005025578A1
(en)
|
2003-09-16 |
2005-03-24 |
Altana Pharma Ag |
Use of ciclesonide for the treatment of respiratory diseases
|
JP2007507466A
(ja)
*
|
2003-10-01 |
2007-03-29 |
アルタナ ファルマ アクチエンゲゼルシャフト |
誘導性noシンターゼ阻害剤としてのイミダゾピリジン誘導体
|
BRPI0415034A
(pt)
*
|
2003-10-01 |
2006-12-12 |
Altana Pharma Ag |
derivados de aminopiridina como inibidores de não-sintase induzìveis
|
US7621273B2
(en)
|
2003-10-28 |
2009-11-24 |
Trudell Medical International |
Indicating device with warning dosage indicator
|
US7100530B2
(en)
|
2003-12-15 |
2006-09-05 |
Trudell Medical International, Inc. |
Dose indicating device
|
AU2005212857B2
(en)
|
2004-02-18 |
2011-04-28 |
Takeda Gmbh |
Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
|
ES2427256T3
(es)
|
2004-03-03 |
2013-10-30 |
Takeda Gmbh |
Nuevas hidroxi-6-heteroaril-fenantridinas y su uso como agentes inhibidores de la PDE4
|
WO2005102354A1
(en)
*
|
2004-04-20 |
2005-11-03 |
Altana Pharma Ag |
Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
|
WO2005102429A1
(en)
|
2004-04-21 |
2005-11-03 |
Innovata Biomed Limited |
Inhaler
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
SI1891974T1
(sl)
|
2004-05-31 |
2010-11-30 |
Almirall Sa |
Kombinacije ki obsegajo antimuskarinska sredstvain PDE innhibitorje
|
WO2006008027A1
(en)
*
|
2004-07-16 |
2006-01-26 |
Laboratorios Almirall, S.A. |
Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler
|
US7543582B2
(en)
|
2004-09-20 |
2009-06-09 |
Trudell Medical International |
Dose indicating device with display elements attached to container
|
PL370286A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy - układ otwierania i opróżniania kapsułek
|
US7743945B2
(en)
|
2005-01-20 |
2010-06-29 |
Trudell Medical International |
Dispensing device
|
NZ560268A
(en)
|
2005-03-02 |
2010-12-24 |
Nycomed Gmbh |
Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
|
EP1866306B1
(en)
|
2005-03-31 |
2009-06-17 |
Nycomed GmbH |
Imidazopyridine derivatives useful as inos inhibitors
|
PL2366393T3
(pl)
|
2005-04-19 |
2014-01-31 |
Takeda Gmbh |
Roflumilast do leczenia nadciśnienia płucnego
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
GB0509225D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of enzymatic activity
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
GB0515584D0
(en)
*
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
EP2281813A1
(en)
|
2005-08-08 |
2011-02-09 |
Pulmagen Therapeutics (Synergy) Limited |
Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
|
GB0516313D0
(en)
|
2005-08-08 |
2005-09-14 |
Argenta Discovery Ltd |
Azole derivatives and their uses
|
DE102005054383B4
(de)
*
|
2005-11-15 |
2013-10-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Nadel zum Lochen von Pulverkapseln für die Inhalation
|
US8464712B2
(en)
*
|
2006-03-10 |
2013-06-18 |
Dose One, Llc |
Medication inhaler
|
US7832399B2
(en)
*
|
2006-03-10 |
2010-11-16 |
One Dose, Llc |
Medication inhaler
|
US8360057B2
(en)
*
|
2006-03-10 |
2013-01-29 |
Dose One, Llc |
Medication inhaler for dispensing multiple capsules
|
US8141550B2
(en)
|
2006-08-01 |
2012-03-27 |
Trudell Medical International |
Dispensing device
|
EP3626289B1
(de)
|
2006-09-15 |
2020-12-02 |
Ypsomed AG |
Injektionsgerät mit verbessertem förderelement
|
GB0619753D0
(en)
|
2006-10-06 |
2006-11-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
US8962825B2
(en)
|
2006-10-30 |
2015-02-24 |
Glaxosmithkline Intellectual Property Development Limited |
Hydroxamates as inhibitors of histone deacetylase
|
GB0622084D0
(en)
|
2006-11-06 |
2006-12-13 |
Chroma Therapeutics Ltd |
Inhibitors of HSP90
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
WO2009046215A2
(en)
*
|
2007-10-02 |
2009-04-09 |
Lab International Srl |
Safety and abuse deterrent improved device
|
DE102007056263A1
(de)
*
|
2007-11-22 |
2009-05-28 |
Siegfried Generics International Ag |
Dosiervorrichtung zur Inhalierung einer pulverförmigen Substanz
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
CA2709071C
(en)
|
2007-12-14 |
2016-11-15 |
Labogroup S.A.S. |
Delivering aerosolizable food products
|
EP2096105A1
(en)
*
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
|
ES2427892T3
(es)
|
2008-02-29 |
2013-11-04 |
Chroma Therapeutics Limited |
Inhibidores de MAP quinasa p38
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2108641A1
(en)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
EP2113503A1
(en)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
|
US8082873B2
(en)
|
2008-05-05 |
2011-12-27 |
Trudell Medical International |
Drive mechanism for an indicating device
|
US8181591B1
(en)
|
2008-05-23 |
2012-05-22 |
Trudell Medical International |
Domed actuator for indicating device
|
RU2376040C1
(ru)
*
|
2008-05-27 |
2009-12-20 |
Александр Григорьевич Чучалин |
Порошковый ингалятор
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
CA2905402C
(en)
|
2008-10-22 |
2017-02-28 |
Trudell Medical International |
Modular aerosol delivery system
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
US8381719B1
(en)
|
2008-12-22 |
2013-02-26 |
Trudell Medical International |
Medicament delivery system with dose indicator and oversleeve actuator
|
ES2442343T3
(es)
|
2008-12-30 |
2014-02-11 |
Pulmagen Therapeutics (Inflammation) Limited |
Compuestos de sulfonamida para el tratamiento de trastornos respiratorios
|
MA33070B1
(fr)
|
2009-01-30 |
2012-02-01 |
Chiesi Farma Spa |
Pyrrolopyrimidinedione dimere et son utilisation dans le traitement de maladies respiratoires
|
EA201190119A1
(ru)
|
2009-02-17 |
2012-05-30 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
ПРОИЗВОДНЫЕ ТРИАЗОЛОПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ МАР-КИНАЗЫ p38
|
GB0902648D0
(en)
|
2009-02-17 |
2009-04-01 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
EP2221297A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
|
EP2221055A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
GB0903480D0
(en)
|
2009-02-27 |
2009-04-08 |
Chroma Therapeutics Ltd |
Enzyme Inhibitors
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
WO2010150014A1
(en)
|
2009-06-24 |
2010-12-29 |
Pulmagen Therapeutics (Inflammation) Limited |
5r- 5 -deuterated glitazones for respiratory disease treatment
|
BR112012003089A2
(pt)
|
2009-08-10 |
2016-08-16 |
Ucl Business Plc |
ligação covalente reversível de moléculas funcionais
|
EP2322176A1
(en)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
WO2011098746A1
(en)
|
2010-02-09 |
2011-08-18 |
Pulmagen Therapeutics (Inflammation) Limited |
Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
|
GB201002224D0
(en)
|
2010-02-10 |
2010-03-31 |
Argenta Therapeutics Ltd |
Respiratory disease treatment
|
GB201004179D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
GB201004178D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
GB201009731D0
(en)
|
2010-06-10 |
2010-07-21 |
Pulmagen Therapeutics Inflamma |
Kinase inhibitors
|
GB201009853D0
(en)
|
2010-06-11 |
2010-07-21 |
Chroma Therapeutics Ltd |
HSP90 inhibitors
|
US8689439B2
(en)
|
2010-08-06 |
2014-04-08 |
Abbott Laboratories |
Method for forming a tube for use with a pump delivery system
|
GB201014023D0
(en)
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Process for producing bioconjugates and products thereof
|
WO2012025701A1
(en)
|
2010-08-25 |
2012-03-01 |
Chroma Therapeutics Ltd. |
Alpha, alpha - di substituted glycine ester derivatives and their use as hdac inhibitors
|
EP2441755A1
(en)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
|
US8377000B2
(en)
|
2010-10-01 |
2013-02-19 |
Abbott Laboratories |
Enteral feeding apparatus having a feeding set
|
US8377001B2
(en)
|
2010-10-01 |
2013-02-19 |
Abbott Laboratories |
Feeding set for a peristaltic pump system
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
RO127873A2
(ro)
|
2011-04-04 |
2012-10-30 |
Salt Pharma S.R.L. |
Dispozitiv de inhalare bifuncţional
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
EP2526945A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
New CRTH2 Antagonists
|
EP2527344A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
|
US20140113877A1
(en)
|
2011-06-15 |
2014-04-24 |
Takeda Gmbh |
Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compounds
|
KR20140037195A
(ko)
|
2011-06-17 |
2014-03-26 |
다케다 게엠베하 |
신규 프탈라지논-피롤로피리미딘카복스아미드 유도체
|
EP2548863A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists.
|
EP2548876A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
RU2622643C2
(ru)
|
2011-09-14 |
2017-06-19 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Производные тетрагидротриазолопиримидина в качестве ингибиторов нейтрофильной эластазы человека
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
EP2592077A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
CN103974953B
(zh)
|
2011-12-09 |
2016-06-29 |
奇斯药制品公司 |
激酶抑制剂
|
KR20140103925A
(ko)
|
2011-12-09 |
2014-08-27 |
키에시 파르마슈티시 엣스. 피. 에이. |
4-히드록시-1,2,3,4-테트라히드로나프탈렌-1-일 우레아 및 호흡기 질환의 치료에서의 이들의 용도
|
HUE029826T2
(en)
|
2011-12-09 |
2017-04-28 |
Chiesi Farm Spa |
Kinase Inhibitors
|
US8327610B1
(en)
|
2011-12-16 |
2012-12-11 |
JCDS Holdings, LLC |
Capsule opener and emptier
|
GB2498746A
(en)
*
|
2012-01-26 |
2013-07-31 |
Innovata Biomed Ltd |
Inhaler which locks when empty
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
EP2647627A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
|
CH706567A2
(de)
|
2012-05-16 |
2013-11-29 |
Tecpharma Licensing Ag |
Verbesserte Vorrichtung zum Einstellen einer Dosis mit einem Begrenzungsmechanismus für ein Gerät zur Verabreichung eines Produkts.
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|
EP2668941A1
(en)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Novel dosage form and formulation of abediterol
|
GB201211310D0
(en)
|
2012-06-26 |
2012-08-08 |
Chroma Therapeutics Ltd |
CSF-1R kinase inhibitors
|
IN2015DN00202A
(pt)
|
2012-07-12 |
2015-06-12 |
Chiesi Farma Spa |
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
RS56184B1
(sr)
|
2012-10-17 |
2017-11-30 |
Macrophage Pharma Ltd |
Terc-butil n-[2-{4-[6-amino-5-(2,4-difluorobenzoil)-2-oksopiridin-1(2h)-il]-3,5-difluorofenil}etil]-l-alaninat ili njegova so, hidrat ili solvat
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
PE20151084A1
(es)
|
2012-12-18 |
2015-08-07 |
Chiesi Farma Spa |
Derivados de pirimidinona inhibidoras de la elastasa de neutrofilos humanos (hne)
|
AP2015008573A0
(en)
|
2012-12-18 |
2015-07-31 |
Almirall Sa |
New cyclohexyl and quinuclidinyl carbamate derivatives having beta 2 adrenergic agonist and M3 muscarinic antagonsit activity
|
US10328210B2
(en)
*
|
2013-02-01 |
2019-06-25 |
Novo Nordisk A/S |
Non-axial working end-of content mechanism and an injection device comprising the same
|
AR094797A1
(es)
|
2013-02-15 |
2015-08-26 |
Almirall Sa |
Derivados de pirrolotriazina como inhibidores de pi3k
|
BR112015029970A2
(pt)
|
2013-06-06 |
2017-07-25 |
Chiesi Farm Spa |
inibidores de cinase
|
EP2848615A1
(en)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
New pyrazole derivatives as CRAC channel modulators
|
DK177788B1
(en)
*
|
2013-07-12 |
2014-07-07 |
Liita Holdings Ltd |
Inhaler
|
EA201690523A1
(ru)
|
2013-09-05 |
2016-07-29 |
Ф. Хоффманн-Ля Рош Аг |
Триазолопиридины, композиции и способы их применения
|
CA2933725A1
(en)
|
2013-12-16 |
2015-06-25 |
Chiesi Farmaceutici S.P.A. |
Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors
|
WO2015091287A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
USD755367S1
(en)
|
2014-03-10 |
2016-05-03 |
Civitas Therapeutics, Inc. |
Indicator for an inhaler
|
NO2709641T3
(pt)
*
|
2014-03-10 |
2018-05-12 |
|
|
USD752204S1
(en)
|
2014-03-10 |
2016-03-22 |
Civitas Therapeutics, Inc. |
Indicator for an inhaler
|
USD752734S1
(en)
|
2014-03-10 |
2016-03-29 |
Civitas Therapeutics, Inc. |
Inhaler grip
|
US9487528B2
(en)
|
2014-06-09 |
2016-11-08 |
Chiesi Farmaceutici S.P.A. |
Compounds
|
LT3221308T
(lt)
|
2014-11-21 |
2018-12-27 |
F2G Limited |
Priešgrybeliniai agentai
|
WO2016170009A1
(en)
|
2015-04-21 |
2016-10-27 |
Almirall, S.A. |
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
WO2017076990A1
(en)
|
2015-11-05 |
2017-05-11 |
Almirall, S.A. |
Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide
|
DE102015119617A1
(de)
*
|
2015-11-13 |
2017-05-18 |
Alfred Von Schuckmann |
Handbetätigbarer Inhalator
|
TW201720828A
(zh)
|
2015-11-23 |
2017-06-16 |
赫孚孟拉羅股份公司 |
治療性化合物及組合物以及其使用方法
|
US9890169B2
(en)
|
2015-12-14 |
2018-02-13 |
Chiesi Farmaceutici S.P.A. |
Triazolinone compounds as HNE inhibitors
|
AR107163A1
(es)
|
2015-12-23 |
2018-03-28 |
Chiesi Farm Spa |
Inhibidores de quinasa
|
AR107165A1
(es)
|
2015-12-23 |
2018-03-28 |
Chiesi Farm Spa |
Inhibidores de quinasa
|
EP3394060A1
(en)
|
2015-12-23 |
2018-10-31 |
Chiesi Farmaceutici S.p.A. |
1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urea derivatives and their use as p38 mapk inhibitors
|
EP3411100A1
(en)
|
2016-02-02 |
2018-12-12 |
Novo Nordisk A/S |
A hypocycloid end-of-content mechanism
|
CN109476638B
(zh)
|
2016-05-05 |
2021-12-28 |
豪夫迈·罗氏有限公司 |
吡唑衍生物、其组合物及治疗用途
|
GB201609222D0
(en)
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|
EP3464269B1
(en)
|
2016-05-31 |
2020-04-01 |
Chiesi Farmaceutici S.p.A. |
Heterocyclic compounds for use in the treatment of a hne related disease
|
JP6990663B2
(ja)
|
2016-05-31 |
2022-01-13 |
シエッシ ファーマスーティシ エス.ピー.エー. |
ヒト好中球エラスターゼ阻害剤としてのイミダゾロン化合物
|
EP3464268B1
(en)
|
2016-05-31 |
2020-03-11 |
Chiesi Farmaceutici S.p.A. |
Novel compounds
|
SG11201901954XA
(en)
|
2016-09-06 |
2019-04-29 |
Hoffmann La Roche |
8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereof
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|
CR20190310A
(es)
|
2016-12-29 |
2019-08-21 |
Hoffmann La Roche |
Compuestos de pirazolopirimidina y métodos de uso de los mismos
|
CN110494434B
(zh)
|
2017-03-14 |
2022-05-24 |
豪夫迈·罗氏有限公司 |
吡唑并氯苯基化合物、其组合物及其使用方法
|
US9861578B1
(en)
*
|
2017-05-11 |
2018-01-09 |
Yuri Issac Busiashvili |
Sublingual dosimetric drip caged ball valve device
|
EP3630766A1
(en)
|
2017-05-22 |
2020-04-08 |
H. Hoffnabb-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
WO2018215390A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
US10364245B2
(en)
|
2017-06-07 |
2019-07-30 |
Chiesi Farmaceutici S.P.A. |
Kinase inhibitors
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
GB201713975D0
(en)
|
2017-08-31 |
2017-10-18 |
Macrophage Pharma Ltd |
Medical use
|
SG11202003062QA
(en)
|
2017-10-09 |
2020-04-29 |
Pearl Therapeutics Inc |
Drug delivery systems and related methods
|
WO2019139714A1
(en)
|
2018-01-15 |
2019-07-18 |
Genentech, Inc. |
Pyrazolopyrimidine compounds as jak inhibitors
|
EA039533B1
(ru)
*
|
2018-03-07 |
2022-02-08 |
Перл Терапьютикс, Инк. |
Устройство для доставки лекарств
|
WO2020011661A1
(en)
|
2018-07-13 |
2020-01-16 |
Kinarus Ag |
Combinations of ppar agonists and p38 kinase inhibitors for preventing or treating fibrotic diseases
|
US11819503B2
(en)
|
2019-04-23 |
2023-11-21 |
F2G Ltd |
Method of treating coccidioides infection
|
US20200399274A1
(en)
|
2019-06-18 |
2020-12-24 |
Genentech, Inc. |
Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereof
|
BR112021025618A2
(pt)
|
2019-06-18 |
2022-02-01 |
Hoffmann La Roche |
Composto, método para prevenir, tratar ou diminuir a gravidade de uma doença, composição farmacêutica e uso de um composto
|
JP2022537354A
(ja)
|
2019-06-18 |
2022-08-25 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Jakキナーゼのピラゾロピリミジンアリールエーテル阻害剤及びその使用
|
GB202002639D0
(en)
|
2020-02-25 |
2020-04-08 |
Ucl Business Ltd |
Therapy
|
WO2022034031A1
(en)
|
2020-08-11 |
2022-02-17 |
Kinarus Ag |
Methods of preventing or treating covid-19 and related viral diseases or disorders
|
AR128054A1
(es)
|
2021-12-22 |
2024-03-20 |
Chiesi Farm Spa |
Sal derivada de triazolona como inhibidor de elastasa de neutrófilos
|
WO2023118252A1
(en)
|
2021-12-22 |
2023-06-29 |
Chiesi Farmaceutici S.P.A. |
Triazolone derivative salt as neutrophil elastase inhibitor
|
WO2023208982A1
(en)
|
2022-04-27 |
2023-11-02 |
Chiesi Farmaceutici S.P.A. |
Crystal form of a pde4 inhibitor
|